8th Modern Drug Discovery & Development Summit
Conference - Philadelphia, PA, US
Productivity in the pharmaceutical industry is lagging. It is now clear that the traditional pharmaceutical research and development model is not sustainable. New technological innovations may mitigate the situation, but they will not sufficiently reverse the inexorable decline in productivity to salvage the traditional R&D model. Instead, radically different research business models must be developed, tested and implemented. Failure to do so poses a grave threat to the future of the pharmaceutical industry.
Despite such a challenge, new government regulation in areas such as stem cell research and recent advances in technology, as seen in transitional medicine, do present the industry with opportunities to push forward and prosper. Exploring these future opportunities is at the center of the 8th Modern Drug Discovery & Development (M3D) Summit in Philadelphia, PA on October 24-26, 2012.
Website: http://www.gtcbio.com/
Wed, Oct 24, 2012 - Fri, Oct 26, 2012
Pennsylvania Convention Center, Philadelphia, PA
Philadelphia, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.